Lumbar spinal stenosis
disease diseaseOn this page
Also known as lumbar region of vertebral column spinal stenosisspinal stenosis of lumbar regionspinal stenosis of lumbar region of vertebral column
Summary
Lumbar spinal stenosis (MONDO:0044753) is a disease and 202 clinical trials. Top therapeutic interventions include dexamethasone sodium phosphate, diphenhydramine, and methylprednisolone acetate. A subtype of spinal stenosis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Clinical trials: 202
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | lumbar spinal stenosis |
| Mondo ID | MONDO:0044753 |
| NCIT | C177445 |
| SNOMED CT | 18347007 |
| UMLS | C0158288 |
| MedGen | 488791 |
| Anatomy (UBERON) | UBERON:0006074 |
| Is cancer (heuristic) | no |
Also known as: lumbar region of vertebral column spinal stenosis · lumbar spinal stenosis · spinal stenosis of lumbar region · spinal stenosis of lumbar region of vertebral column
Data availability: 1 HPO phenotype.
Disease family
This is a subtype of spinal stenosis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorder › skeletal system disorder › vertebral column disorder › spinal stenosis › lumbar spinal stenosis
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 202.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 174 |
| PHASE4 | 16 |
| PHASE3 | 4 |
| PHASE2 | 4 |
| EARLY_PHASE1 | 3 |
| PHASE1/PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT05029726 | PHASE4 | RECRUITING | Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery |
| NCT06157177 | PHASE4 | RECRUITING | Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions. |
| NCT00517751 | PHASE4 | TERMINATED | Condition of Approval Study |
| NCT00558129 | PHASE4 | WITHDRAWN | Effects of X-STOP® Versus Laminectomy Study |
| NCT00638443 | PHASE4 | COMPLETED | Lumbar Stenosis Outcomes Research (LUSTOR) |
| NCT00652093 | PHASE4 | TERMINATED | Lumbar Stenosis Outcomes Research II |
| NCT00956631 | PHASE4 | COMPLETED | MiDAS I (Mild® Decompression Alternative to Open Surgery): Vertos Mild Patient Evaluation Study |
| NCT00995371 | PHASE4 | COMPLETED | Study of Epidural Steroid Injection (ESI) Versus Minimally Invasive Lumbar Decompression (Mild®) in Patients With Symptomatic Lumbar Central Canal Stenosis |
| NCT01057641 | PHASE4 | TERMINATED | Study on the Treatment of Degenerative Lumbar Spine Stenosis With a Percutaneous Interspinous Implant |
| NCT01082159 | PHASE4 | COMPLETED | MiDAS II (Mild® Decompression Alternative to Open Surgery): Vertos Mild Patient Evaluation Study |
| NCT01934868 | PHASE4 | COMPLETED | Prolotherapy Versus Epidural Steroid Injections (ESI) for Lumbar Pain Radiating to the Leg |
| NCT02063035 | PHASE4 | COMPLETED | Effectiveness Study of the Drug Tranexamic Acid to Reduce Post-surgery Blood Loss in Spinal Surgery |
| NCT03245671 | PHASE4 | WITHDRAWN | Particulate vs. Nonparticulate Epidural Steroid Injections for Lumbar Foraminal Stenosis |
| NCT03745040 | PHASE4 | SUSPENDED | Liposomal Bupivacaine in One-level Instrumented Posterior Spinal Fusion |
| NCT05345249 | PHASE4 | COMPLETED | Erector Spinae Plane Block as Pain Management After Lumbar Fusion Surgery |
| NCT05871073 | PHASE4 | COMPLETED | Dexamethasone as Adjuvant to Ropivacaine in Wound Infiltration for Postoperative Analgesia Following Spinal Surgery |
| NCT05058287 | PHASE3 | RECRUITING | Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression |
| NCT00405691 | PHASE3 | COMPLETED | Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis |
| NCT00418197 | PHASE3 | UNKNOWN | Total Facet Arthroplasty System®(TFAS®) Clinical Trial |
| NCT04341831 | PHASE3 | UNKNOWN | Does Teicoplanin Powder Use In Lumbar Instrumentation Surgery Reduce Surgical Site Infection |
| NCT04066296 | PHASE2 | RECRUITING | Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine |
| NCT06907849 | PHASE2 | ENROLLING_BY_INVITATION | 124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome |
| NCT06945926 | PHASE2 | NOT_YET_RECRUITING | The Effect of Oxytocin Nasal Spray on Preventing Postoperative Delirium in Elderly Patients Undergoing Orthopedic Surgery |
| NCT00527527 | PHASE2 | COMPLETED | Chiropractic Dosage for Lumbar Stenosis |
| NCT04537026 | PHASE1/PHASE2 | COMPLETED | Sterile Amniotic Fluid Filtrate Epidural Injection. |
| NCT04992572 | EARLY_PHASE1 | RECRUITING | Study Comparing Local/ MAC Anesthesia in Lumbar Decompression |
| NCT07281625 | EARLY_PHASE1 | RECRUITING | Decompressive Laminectomy Versus Laminectomy With Transpedicular Fixation in Lumbar Spinal Stenosis |
| NCT03088306 | EARLY_PHASE1 | COMPLETED | Improving Pain and Reducing Opioid Use (IPaRO) in Lumbar Spine Surgery Patients |
| NCT02007083 | Not specified | ACTIVE_NOT_RECRUITING | The NORDSTEN Studies/ The Spinal Stenosis Study |
| NCT03072927 | Not specified | RECRUITING | MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study |
| NCT03115983 | Not specified | ACTIVE_NOT_RECRUITING | LimiFlex Clinical Trial for the Treatment of Degenerative Spondylolisthesis With Spinal Stenosis |
| NCT03570801 | Not specified | ACTIVE_NOT_RECRUITING | SLIP II Registry: Spinal Laminectomy Versus Instrumented Pedicle Screw Fusion |
| NCT03853356 | Not specified | ACTIVE_NOT_RECRUITING | Evidence For Fusion In Spine With Orthoss® |
| NCT03879447 | Not specified | ACTIVE_NOT_RECRUITING | Effectiveness and Safety of Korean Medicine for Low Back Pain or Sciatica Due to Lumbar Stenosis/Spondylolisthesis |
| NCT04192591 | Not specified | ACTIVE_NOT_RECRUITING | A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE) |
| NCT04273828 | Not specified | RECRUITING | Impact of Muscle Degeneration in Chronic Low Back Pain |
| NCT04540068 | Not specified | RECRUITING | Prediction of TEI Success in Sciatica |
| NCT04876612 | Not specified | RECRUITING | Effect of Limaprost in Combination With Transforaminal Epidural Steroid Injection |
| NCT05273879 | Not specified | RECRUITING | Necessity of Fusion Following Decompression Surgery in Patients With Single-level Lumbar Stenosis |
| NCT05504499 | Not specified | RECRUITING | REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| DEXAMETHASONE SODIUM PHOSPHATE | 4 | 2 |
| DIPHENHYDRAMINE | 4 | 1 |
| METHYLPREDNISOLONE ACETATE | 4 | 1 |
| PREGABALIN | 4 | 1 |
| TRANEXAMIC ACID | 4 | 1 |
| ALANINE | 3 | 1 |
| TEICOPLANIN | 3 | 1 |
| LUFENURON | 2 | 1 |
| CHEMBL2105779 | 0 | 1 |
| CHEMBL2367892 | 0 | 1 |
| CHEMBL1200637 | 0 | 1 |
| CHEMBL4743806 | 0 | 1 |
| TEICOPLANIN A2-3 | -1 | 1 |